Cover art for Peptron Gets Phase 1 Approval for Monthly Obesity Drug

Peptron Gets Phase 1 Approval for Monthly Obesity Drug

Peptron secures South Korea's Phase 1 approval for once-monthly obesity drug PT403, targeting first dose in December.

By ·

Nov 19, 2026

5 cards · 1m 10s · tap to begin

From · · · 1m 10s

Peptron Gets Phase 1 Approval for Monthly Obesity Drug

Peptron secures South Korea's Phase 1 approval for once-monthly obesity drug PT403, targeting first dose in December.

In brief

Peptron secures South Korea's Phase 1 approval for once-monthly obesity drug PT403, targeting first dose in December. Peptron received South Korea's Ministry of Food and Drug Safety approval for PT403, a once-monthly obesity treatment candidate, with first dose planned for December. Originally reported by BigGo…

Peptron Wins Phase 1 Approval

South Korea's Peptron Wins Phase 1 Approval for Once-Monthly Obesity Drug PT403; First Dose Set for December

Peptron received approval from South Korea's Ministry of Food and Drug Safety for PT403, a once-monthly obesity treatment candidate.

PT403 Uses SmartDepot Platform

PT403 applies Peptron's proprietary SmartDepot platform to semaglutide to extend dosing from weekly to monthly.

First Dose Targeted for December

The company plans to administer the first dose in December after completing follow-up procedures.

Trial at Chungnam National University Hospital

South Korea's Peptron Wins Phase 1 Approval for Once-Monthly Obesity Drug PT403; First Dose Set for December

The Phase 1 trial will evaluate safety, tolerability and pharmacokinetics in 22 healthy adults.

Preclinical Results at ADA Meeting

Peptron presented preclinical results for PT403 at the American Diabetes Association meeting in June.

The key point

Peptron received South Korea's Ministry of Food and Drug Safety approval for PT403, a once-monthly obesity treatment candidate, with first dose planned for December.

Read the original on BigGo Finance

Read the TL;DR — this story on one card.

More news from South Korea

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on peptron and related topics.